Logo

NextGen Signs Asia Distribution Agreements with Cold Spring Biotech and ITS Group

Sep 16, 2004

NEW YORK, Sept. 16 (GenomeWeb News) - Cold Spring Biotech and ITS Group will distribute NextGen's products in six Asian countries, NextGen said today.

 

Beijing-based Cold Spring Biotech will sell NextGen Sciences' products to customers in mainland China, while ITS Group will handle the company's distribution in Singapore, Thailand, Malaysia, Vietnam, and Indonesia, said NextGen.

 

"Over the next few months NextGen Sciences will be introducing a suite of new products, and these agreements are part of our strategy to set up a strong network of global distributors prior to product launches," said Grant Cameron, NextGen Commercial Director.

Breaking News
The Scan

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.

Mitochondrial Replacement Therapy Embryos Appear Largely Normal in Single-Cell 'Omics Analyses

Embryos produced with spindle transfer-based mitochondrial replacement had delayed demethylation, but typical aneuploidy and transcriptome features in a PLOS Biology study.

Cancer Patients Report Quality of Life Benefits for Immune Checkpoint Inhibitors

Immune checkpoint inhibitor immunotherapy was linked in JAMA Network Open to enhanced quality of life compared to other treatment types in cancer patients.

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.